Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04467515 |
|---|---|
| Brief Title: | A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer |
| First Submitted : | June 10, 2020 |
| First Submitted that Met QC Criteria : | July 7, 2020 |
| First Posted : | July 13, 2020 |
| Last Update Submitted that Met QC Criteria : | January 26, 2021 |
| Last Update Posted : | January 27, 2021 |